Literature DB >> 11778967

Apoptosis and cell growth inhibition as antitumor effector functions of interferons.

H Strander.   

Abstract

Since their introduction to the clinic some 30 yr ago, interferons (IFNs) have become standard therapy for a range of disorders, including malignant and benign tumors as well as various viral diseases. Although IFNs will induce remissions in some patients with cancer, they are of no benefit or, at best, lead only to minor improvements in the great majority of patients with malignant disease. One of the great challenges of IFN research is to understand the multiple ways by which IFNs influence the behavior of tumor cells and to identify the factors that underlie the resistance of some tumors to IFNs. This review is written with a focus on two anticellular effects of IFN, inhibition of proliferation and induction of apoptosis, possible mechanisms underlying the antitumor action of IFN. In addition, possible reasons for IFN tumor cell resistance are also discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778967     DOI: 10.1385/mo:18:1:3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  93 in total

Review 1.  Are all type I human interferons equivalent?

Authors:  G R Foster; N B Finter
Journal:  J Viral Hepat       Date:  1998-05       Impact factor: 3.728

2.  A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones.

Authors:  M Heyman; A Nordgren; M Jeddi-Tehrani; O Rasool; Y Liu; D Grander; A Ost; B Wallberg; B Johansson
Journal:  Leukemia       Date:  1996-05       Impact factor: 11.528

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

Review 4.  STATs: signal transducers and activators of transcription.

Authors:  J N Ihle
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

5.  Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines.

Authors:  O Sangfelt; S Erickson; S Einhorn; D Grandér
Journal:  Oncogene       Date:  1997-01-30       Impact factor: 9.867

6.  Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.

Authors:  S Erickson; O Sangfelt; J Castro; M Heyman; S Einhorn; D Grandér
Journal:  Cell Growth Differ       Date:  1999-08

7.  A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal.

Authors:  L P Deiss; A Kimchi
Journal:  Science       Date:  1991-04-05       Impact factor: 47.728

8.  Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma.

Authors:  G Brenning; A Ahre; K Nilsson
Journal:  Scand J Haematol       Date:  1985-11

9.  Effects of interferon-alpha on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines.

Authors:  A E Milner; R J Grand; C D Gregory
Journal:  Int J Cancer       Date:  1995-05-04       Impact factor: 7.396

10.  Inhibition of apoptosis by the retinoblastoma gene product.

Authors:  D A Haas-Kogan; S C Kogan; D Levi; P Dazin; A T'Ang; Y K Fung; M A Israel
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  11 in total

Review 1.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

2.  Antiviral therapy in patients after treatment for hepatitis C-related hepatocellular carcinoma.

Authors:  Su Rin Shin; Seung Woon Paik; Geum-Youn Gwak; Moon Seok Choi; Joon Hyoek Lee; Kwang Cheol Koh; Byung Chul Yoo
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

Review 3.  Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.

Authors:  Narayanan Sathish; Yan Yuan
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

4.  Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.

Authors:  Fan Xiu Zhu; Narayanan Sathish; Yan Yuan
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

6.  Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure.

Authors:  Zhiyi Chen; Kun Liang; Jianhua Liu; Mingxing Xie; Xinfang Wang; Qing Lü; Jing Zhang; Lingyun Fang
Journal:  Med Oncol       Date:  2009-01-07       Impact factor: 3.064

7.  Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs.

Authors:  Uzma A Hasan; Christophe Caux; Ivan Perrot; Anne-Claire Doffin; Christine Menetrier-Caux; Giorgio Trinchieri; Massimo Tommasino; Jaromir Vlach
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

8.  Antiproliferative Properties of Type I and Type II Interferon.

Authors:  Joseph Bekisz; Samuel Baron; Corey Balinsky; Angel Morrow; Kathryn C Zoon
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30

Review 9.  Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.

Authors:  Mariana Aris; María Marcela Barrio
Journal:  Front Immunol       Date:  2015-02-09       Impact factor: 7.561

10.  Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.

Authors:  Irina A Tarasova; Alesya V Tereshkova; Anna A Lobas; Elizaveta M Solovyeva; Alena S Sidorenko; Vladimir Gorshkov; Frank Kjeldsen; Julia A Bubis; Mark V Ivanov; Irina Y Ilina; Sergei A Moshkovskii; Peter M Chumakov; Mikhail V Gorshkov
Journal:  Oncotarget       Date:  2017-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.